RecallDepth
Class III Ongoing

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01

This recall is currently active, issued October 1, 2025. It was issued by Granules Pharmaceuticals Inc..

Company
Granules Pharmaceuticals Inc.
Recall Initiated
August 28, 2025
Posted
October 1, 2025
Recall Number
D-0671-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
9,917 bottles
Firm Location
Chantilly, VA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications:

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot#: GPC250178A, Exp Date: 06-22-2027

More recalls by Granules Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls